<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30302652</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>10</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1573-7292</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>09</Day>                    </PubDate>                </JournalIssue>                <Title>Familial cancer</Title>                <ISOAbbreviation>Fam. Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10689-018-0110-6</ELocationID>            <Abstract>                <AbstractText>Approximately 27-36 million patients in Europe have one of the ~ 5.000-8.000 known rare diseases. These patients often do not receive the care they need or they have a substantial delay from diagnosis to treatment. In March 2017, twenty-four European Reference Networks (ERNs) were launched with the aim to improve the care for these patients through cross border healthcare, in a way that the medical knowledge and expertise travels across the borders, rather than the patients. It is expected that through the ERNs, European patients with a rare disease get access to expert care more often and more quickly, and that research and guideline development will be accelerated resulting in improved diagnostics and therapies. The ERN on Genetic Tumour Risk Syndromes (ERN GENTURIS) aims to improve the identification, genetic diagnostics, prevention of cancer, and treatment of European patients with a genetic predisposition for cancer. The ERN GENTURIS focuses on syndromes such as hereditary breast cancer, hereditary colorectal cancer and polyposis, neurofibromatosis and more rare syndromes e.g. PTEN Hamartoma Tumour Syndrome, Li Fraumeni Syndrome and hereditary diffuse gastric cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Vos</LastName>                    <ForeName>Janet R</ForeName>                    <Initials>JR</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Human Genetics, Radboud University Medical Center, P.O. box 9101, 6500 HB, Nijmegen, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Giepmans</LastName>                    <ForeName>Lisette</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Research B.V, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Röhl</LastName>                    <ForeName>Claas</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Patient representative, European Patient Advocacy Group, European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS), Vienna, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Geverink</LastName>                    <ForeName>Nicoline</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hoogerbrugge</LastName>                    <ForeName>Nicoline</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Human Genetics, Radboud University Medical Center, P.O. box 9101, 6500 HB, Nijmegen, The Netherlands. nicoline.hoogerbrugge@radboudumc.nl.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Coordinator European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands. nicoline.hoogerbrugge@radboudumc.nl.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <CollectiveName>ERN GENTURIS</CollectiveName>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>09</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Fam Cancer</MedlineTA>            <NlmUniqueID>100898211</NlmUniqueID>            <ISSNLinking>1389-9600</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Cross border health care</Keyword>            <Keyword MajorTopicYN="N">European Reference Network</Keyword>            <Keyword MajorTopicYN="N">Genetic</Keyword>            <Keyword MajorTopicYN="N">Hereditary cancer</Keyword>            <Keyword MajorTopicYN="N">Rare diseases</Keyword>            <Keyword MajorTopicYN="N">Syndrome</Keyword>        </KeywordList>        <InvestigatorList>            <Investigator ValidYN="Y">                <LastName>Hoogerbrugge</LastName>                <ForeName>Nicoline</ForeName>                <Initials>N</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Ligtenberg</LastName>                <ForeName>Marjolijn</ForeName>                <Initials>M</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Kets</LastName>                <ForeName>Marleen</ForeName>                <Initials>M</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Sijmons</LastName>                <ForeName>Rolf</ForeName>                <Initials>R</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Evans</LastName>                <ForeName>Gareth</ForeName>                <Initials>G</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Woodward</LastName>                <ForeName>Emma</ForeName>                <Initials>E</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Tischkowitz</LastName>                <ForeName>Marc</ForeName>                <Initials>M</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Maher</LastName>                <ForeName>Eamonn</ForeName>                <Initials>E</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Steinke-Lange</LastName>                <ForeName>Verena</ForeName>                <Initials>V</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Holinski-Feder</LastName>                <ForeName>Elke</ForeName>                <Initials>E</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Frebourg</LastName>                <ForeName>Thierry</ForeName>                <Initials>T</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Houdayer</LastName>                <ForeName>Claude</ForeName>                <Initials>C</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Ferner</LastName>                <ForeName>Rosalie E</ForeName>                <Initials>RE</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Lubinski</LastName>                <ForeName>Jan</ForeName>                <Initials>J</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Ertmanska</LastName>                <ForeName>Karolina</ForeName>                <Initials>K</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Lagercrantz</LastName>                <ForeName>Svetlana Bajalica</ForeName>                <Initials>SB</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Tham</LastName>                <ForeName>Emma</ForeName>                <Initials>E</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Blanco Guillermo</LastName>                <ForeName>Ignacio</ForeName>                <Initials>I</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Capella</LastName>                <ForeName>Gabriel</ForeName>                <Initials>G</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Brunet Vidal</LastName>                <ForeName>Joan</ForeName>                <Initials>J</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Lázaro</LastName>                <ForeName>Conxi</ForeName>                <Initials>C</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Balmaña</LastName>                <ForeName>Judith</ForeName>                <Initials>J</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Bours</LastName>                <ForeName>Vincent</ForeName>                <Initials>V</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Legius</LastName>                <ForeName>Eric</ForeName>                <Initials>E</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Wolkenstein</LastName>                <ForeName>Pierre</ForeName>                <Initials>P</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Melegh</LastName>                <ForeName>Bela</ForeName>                <Initials>B</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Oliveira</LastName>                <ForeName>Carla</ForeName>                <Initials>C</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Teixeira</LastName>                <ForeName>Manuel</ForeName>                <Initials>M</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Poppe</LastName>                <ForeName>Bruce</ForeName>                <Initials>B</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Claes</LastName>                <ForeName>Kathleen</ForeName>                <Initials>K</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Salvador Hernandez</LastName>                <ForeName>Hector</ForeName>                <Initials>H</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Aretz</LastName>                <ForeName>Stefan</ForeName>                <Initials>S</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Spier</LastName>                <ForeName>Isabel</ForeName>                <Initials>I</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Oostenbrink</LastName>                <ForeName>Rianne</ForeName>                <Initials>R</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Krajc</LastName>                <ForeName>Mateja</ForeName>                <Initials>M</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Blatnik</LastName>                <ForeName>Ana</ForeName>                <Initials>A</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Schröck</LastName>                <ForeName>Evelin</ForeName>                <Initials>E</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Peltonen</LastName>                <ForeName>Sirkku</ForeName>                <Initials>S</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Hietala</LastName>                <ForeName>Marja</ForeName>                <Initials>M</Initials>            </Investigator>            <Investigator ValidYN="Y">                <LastName>Colas</LastName>                <ForeName>Chrystelle</ForeName>                <Initials>C</Initials>            </Investigator>        </InvestigatorList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>11</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30302652</ArticleId>            <ArticleId IdType="doi">10.1007/s10689-018-0110-6</ArticleId>            <ArticleId IdType="pii">10.1007/s10689-018-0110-6</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>